Every drop contains
The G200 originates in the lineage of KUSH lines, and in hybrids of lines from Pakistan, Afghanistan and Thailand. G200 is a hybrid variety with a strong tendency to Indica. The strain is part of the G-nnovation series from Canonic, based on innovation in the world of genetics.
Linalool is found in lavender, rose and basil. There is evidence that it has anti-cancer and antioxidant properties and contributes to the reduction of seizures and pain. It can help fight the effects of inflammation and oxidation, protect nerve and liver cells, and expel infections. Linalool is found to have a calming and antidepressant effect.
B-Caryophyllene is found in a large number of plants such as cloves, rosemary, black pepper and lavender. Scientific literature indicates that b-Caryophyllene aids in the protection of various cells in the nervous system, increasing appetite and ability to manage pain during withdrawal from addictions, such as alcoholism. It also has the potential to treat inflammation, multiple sclerosis and Parkinson’s.
It can be found in volatile compounds of many herbs. Scientific literature provides evidence that it inhibits lung cancer of non-small cells.
a-Humulene is a common chemical compound in sage, ginseng, and certain plants in the Hadassi family. It has a particular characteristic aroma – In fact, it’s what gives beer its “hoppy” flavor! Scientific research suggests that terpene and its derivatives show anti-allergic, anti-inflammatory, and anti-cancer potential.
* This information herein does not constitute a binding opinion and should not be relied upon except as a general review, which is not a substitute for a professional medical opinion. CANONIC cannot guarantee and is not responsible that the effects described, or similar effects, will be felt by patients. The information should not be construed as advertisement and / or recommendation and / or encouragement for the use of cannabis, which is a prohibited use by law, other than for medical purposes. The use of medical cannabis is subject to the recommendation of a specialist doctor and in accordance with a suitable license from the Ministry of Health according to law.
You can help us develop better products! Canonic invites you to share with us experiences from the treatment. Combined with our extensive genetic databases, your feedback can help create strains that are better suited to patients’ needs. Join us and together we will improve the therapeutic experience.